In addition, a prospective study on patients treated with cisplatin and paclitaxel evidenced a significant correlation between the severity of the peripheral neurotoxicity and the circulating levels of NGF [54]; in particular, a decrease in NGF circulating levels was observed during cisplatin and L-OHP administration in rats closely correlated with the onset of peripheral neuropathy [57]. This evidence concerns the gene NGF and peripheral neuropathy.